Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
88494 trials found · Page 109 of 4425
-
Major trial tests new drug combo to stop breast Cancer's return
Disease control OngoingThis is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib to standard adjuvant endocrine therapy for patients with HR+ / HER2- early breast cancer (EBC). The purpose of the PALLAS study is…
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
Stem cell transplant vs standard chemo: which works better for brain cancer?
Disease control OngoingThe purpose of this study is to find out what effects (good and/or bad) treatment with chemotherapy and stem cell transplant compared with chemotherapy alone will have on primary CNS B-cell lymphoma. Currently the best treatment for patients with primary CNS B-cell lymphoma is no…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
Off-the-Shelf CAR-T cells take on tough leukemia
Disease control Not yet recruitingAcute myeloid leukemia (AML) is a common type of acute leukemia in adults. Although the treatment of AML has improved in recent decades, the 5-year survival rate remains below 50% due to the chemoresistance or toxicity of these treatments. Most patients eventually die from relaps…
Phase: PHASE1 • Sponsor: Mingfeng Zhao • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
Gene therapy breakthrough? new trial targets Wilson's disease
Disease control Not yet recruitingThe goal of this clinical trial is to learn if GC310 (AAV5-ATP7B) gene therapy can treat Wilson's Disease (WD) in patients over the age of 18 years old. The main questions it aims to answer are: Is GC310 safe and tolerable to WD patients? What is the recommended phase II dose (R…
Phase: PHASE1, PHASE2 • Sponsor: GeneCradle Inc • Aim: Disease control
Last updated May 01, 2026 07:22 UTC
-
Pill could replace hospital IVs for leukemia patients
Disease control Not yet recruitingLATITUDE: A Phase 3, Randomized, Open-Label, 3-Cohort, 2-Period, 2- Sequence, Crossover Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of Oral Arsenic Trioxide Versus Intravenous Arsenic Trioxide for Consolidation Therapy in Participants With Newly Diagnosed, Non-Hi…
Phase: PHASE3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Apr 08, 2026 12:03 UTC
-
Could a Pre-Transfer drug boost stroke recovery?
Disease control Recruiting nowThis study will address the efficacy and safety of Tenecteplase administered in non-endovascular capable center (nECC) in patients with acute ischemic stroke (AIS) caused by anterior circulation large vessel occlusion (acLVO) who present in the 4.5- to 24-hour time window before …
Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 01, 2026 07:22 UTC
-
New blood test could catch cancers early in veterans
Diagnosis Recruiting nowThe purpose of this research study is to evaluate the possible benefits of an investigational, but commercially available Galleri multi-cancer early detection (MCED) blood test which is designed to detect many types of cancer early in veterans who have served in the military in a…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Apr 29, 2026 15:04 UTC
-
Blood test could spot cancer early in High-Risk patients
Diagnosis Recruiting nowThe goal of this study is to understand the performance of an experimental blood test that aims to detect early tumors in patients with hereditary cancer syndromes. If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer det…
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated May 01, 2026 07:21 UTC
-
New shot could prevent strokes in heart patients who Can't take pills
Disease control Recruiting nowA study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulat…
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New hope for aggressive brain cancer: experimental drug berubicin faces off against standard care
Disease control OngoingThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard first line therapy will be randomized in a 2:1 ratio to receive berubicin or lomustine for the evaluation of OS. Additional endpoints will inclu…
Phase: PHASE2 • Sponsor: CNS Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Face transplants give new hope to trauma survivors
Disease control CompletedAllotransplantation of maxillofacial of subject with severe facial deformities due to traumatic events.
Phase: NA • Sponsor: Methodist Health System • Aim: Disease control
Last updated May 01, 2026 07:23 UTC
-
50,000-Person trial: is colonoscopy really better than a simple stool test?
Prevention OngoingColorectal cancer (CRC) is currently the second most common cause of cancer death in the United States, and one of the most preventable cancers. It has been shown in several randomized controlled trials that screening using fecal occult blood testing (FOBT) reduces CRC mortality …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Apr 26, 2026 19:39 UTC
-
Womb transplants offer hope for women unable to carry a baby
Disease control ENROLLING_BY_INVITATIONTransplantation of an uterus
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated May 01, 2026 07:23 UTC
-
Could stem cells ease Parkinson's symptoms? new trial launches
Disease control Not yet recruitingThis clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments t…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated May 01, 2026 07:23 UTC
-
Under-the-Skin shot aims to stop leukemia relapse
Disease control Not yet recruitingTo find out if giving blinatumomab as injections under the skin can help to control MRD and keep the disease from coming back in participants with B-cell ALL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Can a single CAR t infusion wipe out hidden lymphoma cells?
Disease control Not yet recruitingThe goal of the main clinical research study is to learn if treatment with a chimeric antigen receptor (CAR) T-cell therapy called lisocabtagene maraleucel (liso-cel) can help to prevent recurrence of large B-cell cell lymphoma in patients who have achieved complete response (CR)…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New catheter could restore blood flow fast in stroke emergencies
Disease control Not yet recruitingProspective, single-arm, multi-center study to confirm the performance and safety of the iNstroke 6F and 4F thromboaspiration catheter for the treatment of acute ischemic stroke
Phase: NA • Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Light-activated drug combo targets hard-to-treat lung cancer in new trial
Disease control Not yet recruitingThis phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 in combination with cemiplimab works in treating patients with stage IIIB-IV non-small cell lung cancer (NSCLC) that has not responded to previous treatment (refractory), that is not suitable for surgery (i…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Double CAR T-Cell attack may stop leukemia from coming back
Disease control Not yet recruitingBackground: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy involves taking immune cells (T cells) from a person and modifying them to better target cancer cells. CAR T-cell therapy that targets a marker called CD19 has been …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New personalized combo could let some stomach cancer patients skip surgery
Disease control Not yet recruitingThis study will test a new personalized treatment approach for patients with stomach or esophageal cancer. It will take place in two stages and aims to find the best combination of chemotherapy, immunotherapy, and targeted drugs based on each patient's tumor biomarkers. Upon enr…
Phase: PHASE2 • Sponsor: American Association for Cancer Research • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC